Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;48(4):1129-1166.
doi: 10.1007/s11064-022-03772-0. Epub 2022 Nov 3.

The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics

Jared VanderZwaag  1   2 , Torin Halvorson  2   3   4 , Kira Dolhan  5   6 , Eva Šimončičová  1   2 , Benneth Ben-Azu  2   7 , Marie-Ève Tremblay  8   9   10   11   12   13   14   15
Affiliations
Review

The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics

Jared VanderZwaag et al. Neurochem Res. 2023 Apr.

Abstract

There is much excitement surrounding recent research of promising, mechanistically novel psychotherapeutics - psychedelic, anesthetic, and dissociative agents - as they have demonstrated surprising efficacy in treating central nervous system (CNS) disorders, such as mood disorders and addiction. However, the mechanisms by which these drugs provide such profound psychological benefits are still to be fully elucidated. Microglia, the CNS's resident innate immune cells, are emerging as a cellular target for psychiatric disorders because of their critical role in regulating neuroplasticity and the inflammatory environment of the brain. The following paper is a review of recent literature surrounding these neuropharmacological therapies and their demonstrated or hypothesized interactions with microglia. Through investigating the mechanism of action of psychedelics, such as psilocybin and lysergic acid diethylamide, ketamine, and propofol, we demonstrate a largely under-investigated role for microglia in much of the emerging research surrounding these pharmacological agents. Among others, we detail sigma-1 receptors, serotonergic and γ-aminobutyric acid signalling, and tryptophan metabolism as pathways through which these agents modulate microglial phagocytic activity and inflammatory mediator release, inducing their therapeutic effects. The current review includes a discussion on future directions in the field of microglial pharmacology and covers bidirectional implications of microglia and these novel pharmacological agents in aging and age-related disease, glial cell heterogeneity, and state-of-the-art methodologies in microglial research.

Keywords: Anesthetics; Depression; Ketamine; Microglia; Plasticity; Psychedelics.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dragunow M (2020) Human Brain Neuropharmacology: A Platform for Translational Neuroscience. Trends Pharmacol Sci 41:777–792. https://doi.org/10.1016/j.tips.2020.09.002 - DOI - PubMed
    1. Liebner S, Dijkhuizen RM, Reiss Y et al (2018) Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol (Berl) 135:311–336. https://doi.org/10.1007/s00401-018-1815-1 - DOI - PubMed
    1. Cipresso P, Immekus JC (2017) Back to the Future of Quantitative Psychology and Measurement: Psychometrics in the Twenty-First Century. Front Psychol 8:2099. https://doi.org/10.3389/fpsyg.2017.02099 - DOI - PubMed - PMC
    1. Bandelow B, Michaelis S (2015) Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci 17:327–335 - DOI - PubMed - PMC
    1. Vos T, Lim SS, Abbafati C et al (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 396:1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9 - DOI

LinkOut - more resources